The Latest Analyst Ratings for BeiGene
Portfolio Pulse from Benzinga Insights
Over the past 3 months, 7 analysts have published their opinion on BeiGene (NASDAQ:BGNE) stock. The majority of the ratings are bullish or somewhat bullish. The average 12-month price target for BeiGene is $270.71, a decrease of 14.78% from the previous average price target of $317.67.
September 12, 2023 | 3:00 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Analysts have given BeiGene a majority of bullish or somewhat bullish ratings, with an average 12-month price target of $270.71, down 14.78% from the previous target.
The majority of analysts have given bullish or somewhat bullish ratings to BeiGene, indicating a positive outlook for the stock. However, the decrease in the average 12-month price target could suggest a potential slowdown in the stock's growth, which investors should take into account.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100